Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 20,23-dipiperidinyl-mycaminosyl-tylonolide
1. Schembl4567037
2. Ncgc00483033-01
Molecular Weight | 734.0 g/mol |
---|---|
Molecular Formula | C41H71N3O8 |
XLogP3 | 4.3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 9 |
Exact Mass | 733.52411623 g/mol |
Monoisotopic Mass | 733.52411623 g/mol |
Topological Polar Surface Area | 132 Ų |
Heavy Atom Count | 52 |
Formal Charge | 0 |
Complexity | 1170 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 5 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
* 40-mg/ml solution for injection for pigs:
Treatment and metaphylaxis of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica and Haemophilus parasuis sensitive to tildipirosin.
The presence of the disease in the herd should be confirmed before metaphylaxis is implemented.
* 180-mg/ml solution for injection for cattle:
For the treatment and prevention of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni sensitive to tildipirosin.
The presence of the disease in the herd should be confirmed before preventive treatment.
QJ01FA
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Tildipirosin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tildipirosin, including repackagers and relabelers. The FDA regulates Tildipirosin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tildipirosin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tildipirosin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tildipirosin supplier is an individual or a company that provides Tildipirosin active pharmaceutical ingredient (API) or Tildipirosin finished formulations upon request. The Tildipirosin suppliers may include Tildipirosin API manufacturers, exporters, distributors and traders.
click here to find a list of Tildipirosin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tildipirosin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tildipirosin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tildipirosin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tildipirosin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tildipirosin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tildipirosin suppliers with NDC on PharmaCompass.
Tildipirosin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tildipirosin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tildipirosin GMP manufacturer or Tildipirosin GMP API supplier for your needs.
A Tildipirosin CoA (Certificate of Analysis) is a formal document that attests to Tildipirosin's compliance with Tildipirosin specifications and serves as a tool for batch-level quality control.
Tildipirosin CoA mostly includes findings from lab analyses of a specific batch. For each Tildipirosin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tildipirosin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tildipirosin EP), Tildipirosin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tildipirosin USP).
LOOKING FOR A SUPPLIER?